AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.
Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz
Published 4 hours ago
Source: techcrunch.com
Categories
AIBiotech & HealthStartupsAI drug discoveryArtificial Intelligence (AI)converge bio
Related Articles from techcrunch.com
10 minutes ago
ElevenLabs CEO says the voice AI startup crossed $330 million ARR last year
1 hour ago
Apple launches ‘Creator Studio’ bundle of apps for $12.99 per month
2 hours ago
Deepgram raises $130M at $1.3B valuation and buys a YC AI startup
3 hours ago
Slackbot is an AI agent now
3 hours ago
Superorganism raises $25M to back biodiversity startups
4 hours ago